Missing/wrong data?
Log in to edit
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
scientific article published on 04 April 2019
Author/s
author: Ewa Kalinka-Warzocha, Özden Altundağ
Work details
Publication date
April 4, 2019
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.